recall
saveProRx LLC recall (Cls II)
November 5, 2025updated 5mo ago
community read0 votes
Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03 — Reason: Lack of Assurance of Sterility — Status: Ongoing
view source ↗Data sources
last refreshed 6m ago
Found something off?
same company · ±60 days · 4
🐶 often sniffed alongside
top 8- tagApproval150 co-mentions · 75 sources
- drugMOUNJARO48 co-mentions · 24 sources
- drugZEPBOUND48 co-mentions · 24 sources
- drugtirzepatide48 co-mentions · 24 sources
- drugTRULICITY44 co-mentions · 22 sources
- drugdulaglutide44 co-mentions · 22 sources
- drugselpercatinib38 co-mentions · 19 sources
- drugRETEVMO38 co-mentions · 19 sources
comments(0)
5-min edit window · permanent after that